Dehua Pei

This inventor holds 32 USPTO granted patents and 25 published patent applications and 5 EPO patents. Top assignees: The Ohio State University, Entrada Therapeutics, Inc.. Active years: 2007-2025.

USPTO Granted Patents = 32 (Patent Applications = 25)

% Patents Active = 93.8

EPO Patents = 5 (Patent Applications = 19)

Average Co-Inventor Count = 1.8

ph-index = 6

Forward Citations = 125(Granted Patents)

Company Filing History:

27 out of 1,572

The Ohio State University

patents

5 out of 6

Entrada Therapeutics, Inc.

patents

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

Cyclic Peptidyl Inhibitors

Cell Penetrating Peptides

Polypeptide Conjugates

Small Molecule Ras Inhibitors

Bicyclic Peptidyl Inhibitors

Peptidyl Inhibitors

Chemical Synthesis

Peptide Deformylase Inhibitors

Intracellular Delivery

Mitochondrial Neurogastrointestinal Encephalopathy

Protein-Protein Interactions

Beta-Hairpin Motifs

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12496350 - CYCLIC PEPTIDYL INHIBITORS OF CAL-PDZ BINDING DOMAIN (2025-12-16),

2. 12454552 - Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof (2025-10-28),

3. 12404236 - Non-peptidic cell-penetrating motifs (2025-09-02),

4. 12329799 - Peptidyl inhibitors of calcineurin-NFAT interaction (2025-06-17),

5. 12281181 - Bicyclic peptidyl inhibitors (2025-04-21),

6. 12171838 - Polypeptide conjugates for intracellular delivery of nucleic acids (2024-12-24),

7. 12115224 - Polypeptide conjugates for intracellular delivery of stapled peptides (2024-10-15),

8. 12097237 - Small molecule Ras inhibitors (2024-09-24),

9. 11987821 - Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy (2024-05-21),

10. 11987647 - Cyclic cell-penetrating peptides with one or more hydrophobic residues (2024-05-21),

11. 11878046 - Di-sulfide containing cell penetrating peptides and methods of making and using thereof (2024-01-23),

12. 11859019 - Bicyclic peptidyl inhibitor of tumor necrosis factor-alpha (2024-01-02),

13. 11814341 - Non-peptidic cell-penetrating motifs (2023-11-14),

14. 11793884 - Cyclic peptidyl inhibitors of CAL-PDZ binding domain (2023-10-24),

15. 11673919 - Bicyclic peptidyl inhibitors (2023-06-13),

Title: Inventor Dehua Pei: Pioneering Innovations in Columbus

Introduction: Dehua Pei is a distinguished inventor based in Columbus, Ohio, known for her groundbreaking contributions to the field of biotechnology and pharmaceuticals.

Latest Patents: Dehua Pei holds several patents in the areas of drug discovery, molecular biology, and biochemistry, showcasing her continuous commitment to innovation and research.

Career Highlights: With a career spanning over two decades, Dehua Pei has held key positions in renowned research institutions and biotech companies, where she has led teams in developing novel therapies and technologies.

Collaborations: Throughout her career, Dehua Pei has collaborated with leading scientists, researchers, and pharmaceutical companies globally, fostering a culture of innovation and knowledge exchange.

Conclusion: Dehua Pei's dedication to advancing the frontiers of science and medicine through her inventive spirit and collaborative efforts solidifies her position as a trailblazer in the field of biotechnology.